OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations
Gayathri Ravi, Susan Bal, Laura Joiner, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1300-1306
Open Access | Times Cited: 5
Gayathri Ravi, Susan Bal, Laura Joiner, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1300-1306
Open Access | Times Cited: 5
Showing 5 citing articles:
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy
Utkarsh Goel, Saurabh Zanwar, Andrew J. Cowan, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 357-372
Open Access
Utkarsh Goel, Saurabh Zanwar, Andrew J. Cowan, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 357-372
Open Access
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
Sikander Ailawadhi, Yelak Biru, Solène Clavreul, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 1089-1104
Open Access
Sikander Ailawadhi, Yelak Biru, Solène Clavreul, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 1089-1104
Open Access
An Italian Real-world Multicenter Study of Patients with Refractory/Relapsed Functional High-Risk Multiple Myeloma Patients treated with Second-Line Therapies
Danilo De Novellis, Salvatore Palmieri, Stefano Rocco, et al.
Research Square (Research Square) (2025)
Closed Access
Danilo De Novellis, Salvatore Palmieri, Stefano Rocco, et al.
Research Square (Research Square) (2025)
Closed Access
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide
Yuxin Liu, Clifton C. Mo, Monique Hartley-Brown, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 8, pp. 445-465
Closed Access | Times Cited: 2
Yuxin Liu, Clifton C. Mo, Monique Hartley-Brown, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 8, pp. 445-465
Closed Access | Times Cited: 2
Establishing Measurable Residual Disease Trajectories for Patients on Treatment for Newly Diagnosed Multiple Myeloma as Benchmark for Deployment of T-cell Redirection Therapy
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Research Square (Research Square) (2024)
Open Access
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Research Square (Research Square) (2024)
Open Access
